Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
Emerg Infect Dis
; 30(3): 568-571, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38407158
ABSTRACT
Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaquiline resistance development and the need for rapid drug-resistance testing.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tuberculose Resistente a Múltiplos Medicamentos
Limite:
Adolescent
/
Humans
País/Região como assunto:
Africa
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article